The Hematology & Medical Oncology Department includes specialized teams steeped in the diagnosis and treatment of distinct diseases. These include head and neck cancer, breast cancer, lung cancer, gastrointestinal cancer, sarcoma, leukemia, lymphoma, multiple myeloma and classical hematologic disorders. As a National Organization for Rare Disorders (NORD) Center of Excellence, we also accelerate the diagnosis and treatment of rare cancers. Our practitioners are relentlessly focused on improving outcomes for patients with cancer. This includes investigating treatment efficacy, side effects and quality-of-life factors.
Investigative teams lead breakthroughs in cancer research, bringing patients access to the latest treatment advances, including clinical trials in cell therapy and bispecifics.
Specialized tumor boards and members of national treatment guideline committees bring diverse expert perspectives together to deliver personalized, evidence-based treatment plans, supporting oncologists and hematologists with actionable guidance in the face of a rapidly evolving therapeutic landscape.
Integrated medical, radiation and surgical teams facilitate more informed clinical decisions and a faster time to treatment.
Complimentary specialist-led educational sessions for your healthcare professionals during tumor boards, grand rounds and other meetings. Email cancerspeakers@ccf.org for details.
